Tirzepatide (GLP-1/GIP) 10mg · Synthesize Peptide

Tirzepatide (GLP-1/GIP) 10mg is a premium lyophilized dual receptor agonist supplied exclusively for laboratory research. Manufactured to high purity standards for scientific and in vitro research applications.

Tirzepatide is a synthetic dual incretin receptor agonist that has been studied in preclinical and clinical research for its interaction with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is supplied as a sterile, lyophilized powder intended exclusively for laboratory and scientific research. Each vial contains 10mg of high-purity Tirzepatide manufactured under strict quality standards to support consistency in research applications. Product Specifications • Peptide: Tirzepatide (GLP-1/GIP) • Quantity: 10mg per vial • Appearance: White lyophilized powder • Purity: High purity (refer to Certificate of Analysis when available) • Storage: Store refrigerated. After reconstitution, follow appropriate laboratory storage procedures. Research Applications • GLP-1 receptor research • GIP receptor research • Incretin signaling studies • Metabolic pathway research • Receptor pharmacology studies • Cellular signaling research Research Use Only This product is intended for laboratory research purposes only. It is not approved by the U.S. Food and Drug Administration (FDA) for human or veterinary use when sold as a research reagent and is not intended to diagnose, treat, cure, or prevent any disease. This product should only be handled by qualified research professionals.